OTC : BCLI

Brainstorm Cell Therapeutics Inc.

$0.97 USD

$0.01 (1.04%)

Volume
6.96K
Average Volume
17.64K
Market Capitalization
$10.7M
P/E Ratio
-1.03
Dividend Yield
0.00%
Price Target
Year High
$1.69
Year Low
$0.46
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.02

BCLI Estimated and Actual Revenue by Quarter

BCLI Estimated and Actual EPS by Quarter

BCLI Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
2026-06-30 0 - - - - - -
2026-03-31 0 - - - - - -
2025-12-31 0 - - - - - -
2025-09-30 0 - - - - - -
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 0 -2.43M -2.43M -2.43M - - -
2026-09-30 0 -2.32M -2.32M -2.32M - - -
2026-06-30 0 -3.2M -3.2M -3.2M - - -
2026-03-31 0 -3.97M -3.97M -3.97M - - -
2025-12-31 0 -2.6M -2.6M -2.6M - - -
2025-09-30 0 -4.07M -4.07M -4.07M - - -
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 0 - - - 1 -0.22 -0.22 -0.22
2026-09-30 0 - - - 1 -0.21 -0.21 -0.21
2026-06-30 0 - - - 1 -0.29 -0.29 -0.29
2026-03-31 0 - - - 1 -0.36 -0.36 -0.36
2025-12-31 0 - - - 1 -0.28 -0.28 -0.28
2025-09-30 0 - - - 1 -0.37 -0.37 -0.37